急性胰腺炎入院时肠道菌群可预测出院后糖尿病发生
本研究基于前瞻性多中心P-MAPS试验中277例急性胰腺炎患者的临床与微生物组数据,随访中位2.8年,分析入院时口腔和直肠拭子菌群与出院后并发症的关联。结果显示菌群β多样性与出院后死亡、复发性AP及糖尿病显著相关,基于11个差异物种的岭回归模型预测出院后糖尿病的AUC在匹配队列和全队列分别为94.8%和86.2%。
要点
- 入院时菌群β多样性与出院后死亡、复发性AP和糖尿病显著相关。
- 11物种岭回归模型预测出院后糖尿病AUC达94.8%(匹配队列)和86.2%(全队列)。
- 该模型阳性预测值66.6%、阴性预测值96%、准确率95%,提示高阴性排除价值。
核心结论
- 急性胰腺炎患者入院时微生物组与出院后并发症相关,且独立于AP严重程度、吸烟或饮酒等多重危险因素。
- 入院时菌群对出院后糖尿病具有优秀预测能力,未来可能成为定制化风险评估的分层工具。
研究设计与样本
- 长期随访研究,分析前瞻性多中心Pancreatitis-Microbiome As Predictor of Severity试验中277例AP患者的临床与微生物组数据。
- 口腔拭子n=238、直肠拭子n=249,采用Oxford Nanopore Technologies进行16S rRNA和宏基因组测序。
- 主要终点为微生物组成与出院后死亡、复发性AP、进展为慢性胰腺炎、胰腺外分泌功能不全、糖尿病及胰腺导管腺癌的关联。
- 中位随访时间2.8年。
主要发现
- 基于距离的冗余分析结合主坐标典型分析显示,β多样性(Bray-Curtis)在出院后死亡(p=0.04)、复发性AP(p=0.02)和糖尿病(p=0.03)方面存在显著差异。
- 包含11个差异丰度物种的岭回归模型预测出院后糖尿病,在匹配队列和全队列中的ROC曲线下面积分别为94.8%和86.2%。
- 使用该分类器,阳性预测值为66.6%,阴性预测值为96%,准确率为95%。
临床怎么用
- 入院时菌群特征可用于识别出院后糖尿病高风险患者,阴性预测值达96%有助于排除低风险人群。
- 菌群预测能力独立于AP严重程度、吸烟和饮酒等传统危险因素,可作为现有风险评估的补充。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postdischarge morbidity and mortality is high in acute pancreatitis (AP) and pathophysiological mechanisms remain poorly understood. OBJECTIVES: We aim to investigate the composition of gut microbiota and clinical long-term outcomes of prospectively enrolled patients with AP to predict postdischarge complications. DESIGN: In this long-term follow-up study, we analysed clinical and microbiome data of 277 patients from the prospective multicentre Pancreatitis-Microbiome As Predictor of Severity trial. The primary endpoint was the association of the microbial composition with postdischarge mortality, recurrent AP (RAP), progression to chronic pancreatitis, pancreatic exocrine insufficiency, diabetes mellitus (DM) and pancreatic ductal adenocarcinoma. RESULTS: Buccal (n=238) and rectal (n=249) swabs were analysed by 16S rRNA and metagenomics sequencing using Oxford Nanopore Technologies. Median follow-up was 2.8 years. Distance-based redundancy analysis with canonical analysis of principal coordinates showed significant differences for β-diversity (Bray-Curtis) for postdischarge mortality (p=0.04), RAP (p=0.02) and DM (p=0.03). A ridge regression model including 11 differentially abundant species predicted postdischarge DM with an area under the receiving operating characteristic of 94.8% and 86.2% in the matched and entire cohort, respectively. Using this classifier, a positive predictive value of 66.6%, a negative predictive value of 96% and an accuracy of 95% was achieved. CONCLUSION: Our data indicate that the admission microbiome of patients with AP correlates with postdischarge complications independent from multiple risk factors such as AP severity, smoking or alcohol. Microbiota at admission show excellent capacity to predict postdischarge DM and may thus open new stratification tools for a tailored risk assessment in the future. TRIAL REGISTRATION NUMBER: NCT04777812.
引用
- Ammer-Herrmenau C, Meier R, Antweiler KL, et al. Gut microbiota predict development of postdischarge diabetes mellitus in acute pancreatitis. Gut. 2026. PMID: 41298102. doi:10.1136/gutjnl-2025-336715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。